The article discusses facets of medicine affected by human T-liymphotropic virus type I
(HTLV-I). The presence of serum antibodies to HTLV-I is indicative of infection with this virus …

Infection with human T lymphotropic virus type I (HTLV-I) is associated with neurological
disorders and adult T-cell leu kaemia. Although the global distribution of HTLV-I has not …

Human T-lymphotropic virus type I (HTLV-I) is the etiologic agent of HTLV-I associated
myelopathy (HAM)/tropical spastic paresis (TSP), and adult T-cell leukemia/lymphoma …

Originally identified from a T-lymphoblastoid cell line (HUT 102) of a patient diagnosed with
a cutaneous T-cell lymphoma, the human T-lymphotropic virus type I (HTLV-I) was the first …

Human T lymphotropic virus‐1 (HTLV‐1) is a retrovirus which infects T lymphocytes (CD4+)
to cause adult T cell leukaemia/lymphoma (ATL), tropical spastic paraparesis and several …

HTLV II is a retrovirus endemic in some Amerindian tribes and spread worldwide with a high
prevalence among intravenous drug abusers. It has three different genetic subtypes a, b …

Several studies have reported an association between HTLV-II and a neurological condition
which has come to be called HTLV-II-associated myelopathy and is similar, in some cases …

Two cell lines, CNS-5 and CNS-6, were established by cocultivation of sedimented cells in
cerebrospinal fluid (CSF) from two anti-human T-lymphotropic virus type I (HTLV-I) antibody …

Adult T-cell leukemia, lymphoma (ATL) was first described in 1977 by Uchiyama et al., who
detailed the clinical and hematologic features in 16 patients.'They found that these patients …

Retroviruses have been known to be related to a variety of neoplastic, immunodeficient, and
chronic degenerative disorders (Weiss et al. 1984; Haase 1986) for some time, but the …